{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:23:08Z","timestamp":1761675788470,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","award":["101157011"],"award-info":[{"award-number":["101157011"]}],"id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jim.2025.113981","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T15:11:31Z","timestamp":1759245091000},"page":"113981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Measurement of cleaved high-molecular-weight kininogen in patients with hereditary angioedema due to C1-inhibitor deficiency: preanalytical and analytical optimization"],"prefix":"10.1016","volume":"544","author":[{"given":"Chiara","family":"Suffritti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Gualtierotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Zanichelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Vidali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Cugno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2025.113981_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0162-3109(99)00107-1","article-title":"Angioedema due to angiotensin-converting enzyme inhibitors","volume":"44","author":"Agostoni","year":"1999","journal-title":"Immunopharmacology"},{"issue":"3 Suppl","key":"10.1016\/j.jim.2025.113981_bb0010","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","article-title":"Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond","volume":"114","author":"Agostoni","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jim.2025.113981_bb0015","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1111\/all.14160","article-title":"Impaired control of the contact system in hereditary angioedema with normal C1-inhibitor","volume":"75","author":"Bova","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jim.2025.113981_bb0020","series-title":"Haemostasis and Thrombosis. Basic Principles and Clinical Practice","first-page":"103","article-title":"Contact activation pathway: inflammatory, fibrinolytic, anticoagulant, antiadhesive and antiangiogenic activities","author":"Colman","year":"2001"},{"key":"10.1016\/j.jim.2025.113981_bb0025","first-page":"423","article-title":"Haemostasis contact system and fibrinolysis in hereditary angioedema (C1-inhibitor deficiency)","volume":"26","author":"Cugno","year":"1988","journal-title":"J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.jim.2025.113981_bb0030","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0091-6749(94)90380-8","article-title":"Activation of the contact system and fibrinolysis in autoimmune acquired angioedema: a rationale for prophylactic use of tranexamic acid","volume":"93","author":"Cugno","year":"1994","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jim.2025.113981_bb0035","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1182\/blood.V89.9.3213","article-title":"Activation of the coagulation cascade in C1-inhibitor deficiencies","volume":"89","author":"Cugno","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.jim.2025.113981_bb0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1160\/TH12-11-0792","article-title":"A nanobody-based method for tracking factor XII activation in plasma","volume":"110","author":"de Maat","year":"2013","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jim.2025.113981_bb0045","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59177","article-title":"A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm","volume":"9","author":"Garvin","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.jim.2025.113981_bb0050","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1182\/blood-2018-06-860270","article-title":"A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain","volume":"133","author":"Ivanov","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jim.2025.113981_bb0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1081-1206(10)60493-0","article-title":"Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma","volume":"101","author":"Joseph","year":"2008","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.jim.2025.113981_bb0060","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/1354750X.2013.787544","article-title":"The kinin-kallikrein system: physiological roles, pathophysiology and its relationship to cancer biomarkers","volume":"18","author":"Kashuba","year":"2013","journal-title":"Biomarkers"},{"key":"10.1016\/j.jim.2025.113981_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2022.100627","article-title":"The international WAO\/EAACI guideline for the management of hereditary angioedema - the 2021 revision and update","volume":"15","author":"Maurer","year":"2022","journal-title":"World Allergy Organ J."},{"key":"10.1016\/j.jim.2025.113981_bb0070","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","article-title":"Plasma bradykinin in angio-oedema","volume":"351","author":"Nussberger","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jim.2025.113981_bb0075","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM200208223470820","article-title":"Bradykinin-mediated angioedema","volume":"347","author":"Nussberger","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jim.2025.113981_bb0080","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.873975","article-title":"Plasma Kallikrein cleaved H-kininogen: an end-point marker for contact activation in vitro and ex vivo","volume":"9","author":"Palarasah","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"issue":"3","key":"10.1016\/j.jim.2025.113981_bb0085","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/rth2.12217","article-title":"The contact pathway and sepsis","volume":"3","author":"Raghunathan","year":"2019","journal-title":"Res Pract Thromb Haemost."},{"key":"10.1016\/j.jim.2025.113981_bb0090","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jaci.2024.03.024","article-title":"Definition, acronyms, nomenclature, and classification of angioedema (DANCE): AAAAI, ACAAI, ACARE, and APAAACI DANCE consensus","volume":"154","author":"Reshef","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jim.2025.113981_bb0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/jth.13194","article-title":"The contact activation and kallikrein\/kinin systems: pathophysiologic and physiologic activities","volume":"14","author":"Schmaier","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jim.2025.113981_bb0100","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0049-3848(98)00142-X","article-title":"The pharmacokinetics of the kininogens","volume":"92","author":"Schmaier","year":"1998","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jim.2025.113981_bb0105","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/jth.14595","article-title":"Nomenclature of factor XI and the contact system","volume":"17","author":"Schmaier","year":"2019","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.jim.2025.113981_bb0110","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1055\/s-0038-1655916","article-title":"Rapid direct determination of low and high molecular weight kininogen in human plasma by particle concentration fluorescence immunoassay (PCFIA)","volume":"77","author":"Scott","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jim.2025.113981_bb0115","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/cea.12293","article-title":"High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency","volume":"44","author":"Suffritti","year":"2014","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.jim.2025.113981_bb0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.18176\/jiaci.0996","article-title":"Contact system activation and bradykinin generation in patients with idiopathic angioedema","volume":"34","author":"Suffritti","year":"2024","journal-title":"J. Invest. Allergol. Clin. Immunol."},{"key":"10.1016\/j.jim.2025.113981_bb0125","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.dadm.2018.06.008","article-title":"A novel detection method of cleaved plasma high-molecular-weight kininogen reveals its correlation with Alzheimer\u2019s pathology and cognitive impairment","volume":"10","author":"Yamamoto-Imoto","year":"2018","journal-title":"Alzheimers Dement (Amst)."},{"key":"10.1016\/j.jim.2025.113981_bb0130","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.4155\/bio-2017-0105","article-title":"2D-LC-MS\/MS to measure high-molecular-weight kininogen in human plasma as a biomarker for C1-INH-HAE","volume":"9","author":"Zhang","year":"2017","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jim.2025.113981_bb0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s12016-025-09027-4","article-title":"Hereditary angioedema with Normal C1 inhibitor: an updated international consensus paper on diagnosis, pathophysiology, and treatment","volume":"68","author":"Zuraw","year":"2025","journal-title":"Clin Rev Allergy Immunol"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175925001814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175925001814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:00:06Z","timestamp":1761674406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175925001814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":27,"alternative-id":["S0022175925001814"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2025.113981","relation":{},"ISSN":["0022-1759"],"issn-type":[{"type":"print","value":"0022-1759"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measurement of cleaved high-molecular-weight kininogen in patients with hereditary angioedema due to C1-inhibitor deficiency: preanalytical and analytical optimization","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2025.113981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113981"}}